Recordati

This month, our UK team set off on the Brecon Beacons Four Falls walk in support of the Pituitary Foundation. Covering around 20km, their journey took them through the spectacular woodland scenery of this area, also known as ‘Waterfall Country’. An amazing moment for our team to come together to raise funds for people living with pituitary conditions. The pituitary gland is a small gland at the base of the brain that regulates various hormones. Pituitary conditions disrupt the gland’s functioning, causing excess or insufficient hormone production. This can go on to impact growth, metabolism, and reproductive functions. Together, we’re making strides – both on the trail and for our patient communities. #RecordatiPeople #UnlockingTheFullPotentialOfLife #Fundraising

Our team at Recordati Rare Diseases España has partnered with the non-profit Fundación Juegaterapia (Playtherapy Foundation) to support children receiving treatment for neuroblastoma by introducing the PlayCars project. The project was launched in collaboration with Recordati’s medical team, backed by evidence that video games can significantly reduce discomfort during treatment. The PlayCar station provides access to videogames in the hospital, letting children play while receiving care. So far, five PlayCars are available in hospitals throughout Spain, with plans to expand. The Foundation’s mission is to make the hospital a friendlier place by setting up playrooms or decorating children’s cancer wards. We’re proud of our team for collaborating with Fundación Juegaterapia on this innovative project to help young patients pass the time during their hospital visits.

One year ago, we launched our refreshed purpose: Unlocking the full potential of life. This purpose, co-created with our colleagues, inspires us daily. It drives our commitment to help people be the best version of themselves, whether that is through our work for patients with rare or common diseases or by volunteering in our communities. This drive will never stop. Around 80 of our Culture Ambassadors have worked tirelessly to help our purpose flourish, transforming it from words on paper to a guiding principle throughout Recordati. As we celebrate this milestone, we look forward to continuing to live our purpose and help people live life to the fullest. #Culture #CultureAmbassadors #UnlockingTheFullPotentialOfLife

On World Environment Day we’re delighted to announce that we’re expanding the use of solar power in our plants – continuing our commitment to installing new renewable energy production systems in our manufacturing sites. Following our teams in Spain and Ireland, the Recordati plant in Türkiye is following suit and is now authorised to use its newly completed solar panel system. These solar panels have a maximum power output of around 480 kWp, covering part of the plant's needs. Any further electricity needed for the plant will continue to be purchased from grid, ensuring that it comes from renewable sources. A great example of our sustainability approach through responsible action, protecting our most important assets: people and planet. #WorldEnvironmentDay #Sustainability #PeopleandPlanet

Schizophrenia is a chronic mental health condition that affects around 24 million people worldwide according to the World Health Organization.   This complex mental health disorder blurs the line between reality and hallucinations or delusions, causing profound confusion and disorientation.   Symptoms can also manifest as a loss of motivation, difficulty with memory, focus and executive functioning. Isolation and social stigma add to the challenges faced by people affected.   Recordati, in collaboration with Gedeon Richter stands with patients, caregivers and the medical community in navigating these obstacles. Find out more about the condition at: www.schizophrenia.life   #Schizophrenia #MentalHealthAwareness #WorldSchizophreniaDay #WorldSchizophreniaAwarenessDay

Join us in welcoming Alessandro Gilio as Executive Vice President Group Industrial Operations, bolstering our drive for innovation and excellence in industrial operations. Alessandro joins as a highly accomplished international executive with over 20 years’ experience, with a proven track record of driving growth and enhancing business performance within the pharmaceutical, biotechnology and fast-moving consumer goods sectors. #RecordatiPeople #Recordati #UnlockingTheFullPotentialOfLife

Pleased to announce the winner of the 11th edition of the International Prize for Scientific Research Arrigo Recordati: Adam Durbin, MD PhD. The Prize was established in 2000 in memory of the Italian pharmaceutical entrepreneur Arrigo Recordati to perpetuate his legacy and to inspire biomedical discoveries benefiting people worldwide. Dedicated this year to research in paediatric oncology, specifically neuroblastoma, Dr Durbin’s project was selected from over 40 entries by an independent panel of internationally recognised rare disease experts. The Prize was awarded at the 5th Annual Meeting of the European Society for Paediatric Oncology (SIOP), held in Milan, with Dr Durbin’s project receiving a €100,000 research grant. Click here to read the full press release: https://lnkd.in/evwsqZdk   #RareDisease #Innovation #ArrigoRecordatiPrize #Oncology #OncologyResearch

Our CFO Luigi La Corte appeared as a guest on Class CNBC to discuss the strong momentum of Recordati in Q1 2024, with double-digit revenue growth and sustained margins across our businesses, and good progress of our life cycle management initiatives.   The full interview is available here: https://lnkd.in/eMunAvKB #RecordatiResults #Q12024 #ClassCNBC

Today we announce our 2024 first quarter results, with revenue +10.2%, EBITDA +10.5% and adjusted net income +5.6%. "These results mark an excellent start to the year. Our strong momentum fueled double-digit growth at CER across both the Specialty & Primary Care and Rare Diseases businesses. Our robust performance was broad-based, across all key geographies and products, and helped drive the EBITDA margin in the quarter to just over 40%. This performance is also a testament to the continued commitment of our people. We remain focused on executing on our long-term growth strategy and are confident in delivering the objectives we already set out for 2024 and 2025,” commented CEO Rob Koremans. Read full press release here: https://lnkd.in/evwsqZdk #Results #RecordatiResults #Q12024

Ready to join us at the forefront of life-enhancing and life-changing medicines? Explore Recordati's new Careers Page: https://lnkd.in/eZ2Nb4jh Find exciting opportunities around the world, from R&D and chemical manufacturing to commercialisation and licensing. Join our talent community for updates on opportunities worldwide and let our Talent Acquisition specialists help you find your new position. With its beginnings in a family run pharmacy in Correggio, Italy, in the 1920s, Recordati is now a global pharmaceutical force listed on the Italian stock exchange - with almost 4,500 employees and growing. Join us in our purpose: Unlocking the full potential of life. #RecordatiPeople #Careers